TB Alliance sublicenses promising TB drug from the Medicines Patent Pool

Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer.

Read More →

MSF urges pharmaceutical corporations to release clinical data to help develop urgently needed new TB regimens

Médecins Sans Frontières (MSF) urges Sequella and Pfizer to provide open access to all existing clinical data for sutezolid to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes.

Read More →

Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children

WHO and UNICEF issue joint statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children.

Read More →

Next-generation Xpert® MTB/RIF Ultra assay recommended by WHO

The World Health Organization (WHO) recommends the use of a next-generation Xpert® MTB/RIF assay (called Xpert® MTB/RIF Ultra) as a replacement for the current Xpert MTB/RIF® cartridge.

Read More →

No time to lose: G20 leadership in TB research needed to end TB

Treatment Action Group, Health GAP, AIDS-Free World, and Treatment Action Campaign urge G20 leaders to fund research to end TB.

Read More →

Berlin TB Summit concludes with call for G20 leadership on TB

The Berlin TB Summit concluded with a call for G20 leaders to prioritize TB in their agenda ahead of the G20 Summit in July this year.

Read More →

WHO issues ethics guidance to protect rights of TB patients

World TB Day 2017 – Unite efforts to leave no one behind

Read More →

Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval

Companies and countries must take urgent action to increase access to these life-saving treatments.

Read More →

Call for applications for the Stop TB Partnership Board: TB Affected Communities Board Members

The Stop TB Partnership is seeking applications for new TB Affected Communities Board Members. Application deadline: 31 March 2017.

Read More →

TAG statement on President’s 2018 budget blueprint

Treatment Action Group (TAG) released a statement in strong opposition to the President’s 2018 budget blueprint.

Read More →

Page 1 of 79 · Total posts: 10

1 2 Last→

To subscribe to the Weekly Newsletter of new posts, enter your email here:

Learn About TB